Home
Conditions
Leukemia, Eosinophilic, Acute

Clinical trial condition

Leukemia, Eosinophilic, Acute

Explore clinical trials studying Leukemia, Eosinophilic, Acute. Study availability and eligibility vary by location and protocol.

46 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Eosinophilic, Acute trial results

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00295841

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

NCT00666588

Conditions: Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), +31 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

View all 82 locations

View Trial Details

Completed

Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00775593

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Azienda ospedaliera Nuovo ospedale "Torrette" Ancona, Italy

Azienda Ospedaliero-Universitaria Policlinico Consorziale Bari, Italy

Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Bologna, Italy

Ospedale Ferrarotto Catania, Italy

View all 19 locations

View Trial Details

Completed

A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia

NCT01656031

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

NCT01385150

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Not specified

View Trial Details

Completed

Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531

NCT01407757

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Completed

Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia

NCT01076569

Conditions: Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), +17 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia

NCT01438138

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Not specified

View Trial Details

Completed

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

NCT01360125

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Leukemia, Eosinophilic, Acute

Leukemia, Eosinophilic, Acute trial results

Related conditions